Literature DB >> 19216902

Assessing metabolic stress and autophagy status in epithelial tumors.

Robin Mathew1, Vassiliki Karantza-Wadsworth, Eileen White.   

Abstract

Autophagy is a survival mechanism activated in response to metabolic stress. In normal tissues autophagy plays a major role in energy homeostasis through catabolic self-digestion of damaged proteins and organelles. Contrary to its survival function, autophagy defects are implicated in tumorigenesis suggesting that autophagy is a tumor suppression mechanism. Although the exact mechanism of this tumor suppressor function is not known, it likely involves mitigation of cellular damage leading to chromosomal instability. The complex role of functional autophagy in tumors calls for model systems that allow the assessment of autophagy status, stress management and the impact on oncogenesis both in vitro as well as in vivo. We developed model systems that involve generation of genetically defined, isogenic and immortal epithelial cells from different tissue types that are applicable to both wild-type and mutant mice. This permits the study of tissue- as well as gene-specific tumor promoting functions. We successfully employed this strategy to generate isogenic, immortal epithelial cell lines from wild-type and mutant mice deficient in essential autophagy genes such as beclin 1 (beclin 1(+/-)) and atg5 (atg 5(-/-)). As these cell lines are amenable to further genetic manipulation, they allowed us to generate cell lines with apoptosis defects and stable expression of the autophagy marker EGFP-LC3 that facilitate in vitro and in vivo assessment of stress-mediated autophagy induction. We applied this model system to directly monitor autophagy in cells and 3D-morphogenesis in vitro as well as in tumor allografts in vivo. Using this model system we demonstrated that autophagy is a survival response in solid tumors that co-localizes with hypoxic regions, allowing tolerance to metabolic stress. Furthermore, our studies have established that autophagy also protects tumor cells from genome damage and limits cell death and inflammation as possible means to tumor suppression. Additionally these cell lines provide an efficient way to perform biochemical analyses, and high throughput screening for modulators of autophagy for potential use in cancer therapy and prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19216902      PMCID: PMC2857509          DOI: 10.1016/S0076-6879(08)04004-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  41 in total

1.  Growth factor regulation of autophagy and cell survival in the absence of apoptosis.

Authors:  Julian J Lum; Daniel E Bauer; Mei Kong; Marian H Harris; Chi Li; Tullia Lindsten; Craig B Thompson
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

Review 2.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

3.  Autophagy suppresses tumor progression by limiting chromosomal instability.

Authors:  Robin Mathew; Sameera Kongara; Brian Beaudoin; Cristina M Karp; Kevin Bray; Kurt Degenhardt; Guanghua Chen; Shengkan Jin; Eileen White
Journal:  Genes Dev       Date:  2007-05-17       Impact factor: 11.361

Review 4.  Autophagy: from phenomenology to molecular understanding in less than a decade.

Authors:  Daniel J Klionsky
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

Review 5.  Gene amplification in cancer.

Authors:  Donna G Albertson
Journal:  Trends Genet       Date:  2006-06-19       Impact factor: 11.639

6.  NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition.

Authors:  Tsutomu Shimazu; Kurt Degenhardt; Alam Nur-E-Kamal; Junjie Zhang; Takeshi Yoshida; Yonglong Zhang; Robin Mathew; Eileen White; Masayori Inouye
Journal:  Genes Dev       Date:  2007-04-02       Impact factor: 11.361

7.  The role of autophagy during the early neonatal starvation period.

Authors:  Akiko Kuma; Masahiko Hatano; Makoto Matsui; Akitsugu Yamamoto; Haruaki Nakaya; Tamotsu Yoshimori; Yoshinori Ohsumi; Takeshi Tokuhisa; Noboru Mizushima
Journal:  Nature       Date:  2004-11-03       Impact factor: 49.962

8.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis.

Authors:  Kurt Degenhardt; Robin Mathew; Brian Beaudoin; Kevin Bray; Diana Anderson; Guanghua Chen; Chandreyee Mukherjee; Yufang Shi; Céline Gélinas; Yongjun Fan; Deirdre A Nelson; Shengkan Jin; Eileen White
Journal:  Cancer Cell       Date:  2006-07       Impact factor: 31.743

9.  Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3.

Authors:  Guillermo Mariño; Natalia Salvador-Montoliu; Antonio Fueyo; Erwin Knecht; Noboru Mizushima; Carlos López-Otín
Journal:  J Biol Chem       Date:  2007-04-17       Impact factor: 5.157

10.  Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis.

Authors:  Vassiliki Karantza-Wadsworth; Shyam Patel; Olga Kravchuk; Guanghua Chen; Robin Mathew; Shengkan Jin; Eileen White
Journal:  Genes Dev       Date:  2007-07-01       Impact factor: 11.361

View more
  15 in total

1.  The decreased expression of Beclin-1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid.

Authors:  Heather B Roesly; Mohammad R Khan; Hwu Dau Rw Chen; Kimberly A Hill; Nirushan Narendran; George S Watts; Xiaoxin Chen; Katerina Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-02       Impact factor: 4.052

2.  Bathymodiolamides A and B, ceramide derivatives from a deep-sea hydrothermal vent invertebrate mussel, Bathymodiolus thermophilus.

Authors:  Eric H Andrianasolo; Liti Haramaty; Kerry L McPhail; Eileen White; Costantino Vetriani; Paul Falkowski; Richard Lutz
Journal:  J Nat Prod       Date:  2011-01-11       Impact factor: 4.050

3.  Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis.

Authors:  Y Tian; C-F Kuo; D Sir; L Wang; S Govindarajan; L M Petrovic; J-H J Ou
Journal:  Cell Death Differ       Date:  2014-12-19       Impact factor: 15.828

Review 4.  What is the malignant nature of human ductal carcinoma in situ?

Authors:  Virginia Espina; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2010-12-02       Impact factor: 60.716

Review 5.  Autophagy genes as tumor suppressors.

Authors:  Chengyu Liang; Jae U Jung
Journal:  Curr Opin Cell Biol       Date:  2009-11-28       Impact factor: 8.382

Review 6.  The double-edged sword of autophagy modulation in cancer.

Authors:  Eileen White; Robert S DiPaola
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

7.  How efficient are autophagy inhibitors as treatment for glioblastoma?

Authors:  Jeffrey Wojton; James Elder; Balveen Kaur
Journal:  CNS Oncol       Date:  2014-01

8.  High-throughput screening for natural compound-based autophagy modulators reveals novel chemotherapeutic mode of action for arzanol.

Authors:  Jana Deitersen; Lena Berning; Fabian Stuhldreier; Sara Ceccacci; David Schlütermann; Annabelle Friedrich; Wenxian Wu; Yadong Sun; Philip Böhler; Niklas Berleth; María José Mendiburo; Sabine Seggewiß; Ruchika Anand; Andreas S Reichert; Maria Chiara Monti; Peter Proksch; Björn Stork
Journal:  Cell Death Dis       Date:  2021-05-31       Impact factor: 8.469

9.  Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death.

Authors:  Gabriel Ichim; Jonathan Lopez; Shafiq U Ahmed; Nathiya Muthalagu; Evangelos Giampazolias; M Eugenia Delgado; Martina Haller; Joel S Riley; Susan M Mason; Dimitris Athineos; Melissa J Parsons; Bert van de Kooij; Lisa Bouchier-Hayes; Anthony J Chalmers; Rogier W Rooswinkel; Andrew Oberst; Karen Blyth; Markus Rehm; Daniel J Murphy; Stephen W G Tait
Journal:  Mol Cell       Date:  2015-02-19       Impact factor: 17.970

10.  Stage-stratified analysis of prognostic significance of Bax-interacting factor-1 expression in resected colorectal cancer.

Authors:  Yoon Ho Ko; Young-Seok Cho; Hye Sung Won; Ho Jung An; Der Sheng Sun; Soon Uk Hong; Jin Hee Park; Myung Ah Lee
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.